Latest 10-K annual reports

NASDAQ
Mister Car Wash, Inc. details its Executive Severance Plan, outlining benefits for executive-level employees upon termination under specific conditions.
NYSE
Elme Communities has filed an amendment to its 2025 Form 10-K, primarily to include Part III information and updated certifications.
NASDAQ
Lisata Therapeutics, Inc. has filed an amendment to its 2025 Form 10-K to include previously omitted Part III information regarding corporate governance, executive compensation, and security ownership.
NASDAQ
Beasley Broadcast Group, Inc. files an amendment to its 2025 Annual Report on Form 10-K to include Part III information previously intended for incorporation by reference from its proxy statement.
NASDAQ
Northfield Bancorp, Inc. has filed an Amendment No. 1 to its 2025 Form 10-K to include Part III information, necessitated by its pending acquisition by Columbia Financial, Inc.
OTC.Pink
Sharing Economy International Inc. reported a significant net income of $25.6 million for the fiscal year ended December 31, 2023, primarily driven by a gain from the disposal of subsidiaries, despite generating no revenue from its core sharing economy business.
NASDAQ
Apellis Pharmaceuticals, Inc. has filed an Amendment No. 1 to its Annual Report on Form 10-K for the fiscal year ended December 31, 2025, to include Part III information previously omitted.
NASDAQ
ALT5 Sigma Corporation has filed an amendment to its 2025 Annual Report on Form 10-K, primarily to include its Compensation Recoupment (Clawback) Policy.
OID
Hallmark Venture Group, Inc. files its 2025 Form 10-K, detailing operational shifts, financial performance, and ongoing strategic pursuits.
OQB
International Land Alliance reports a net loss of $14.3 million for fiscal year 2025 amid liquidity challenges and ongoing development projects in Mexico.
OTC.Pink
American Rebel Holdings, Inc. filed an amendment to its 2025 Annual Report to include a previously omitted Executive Compensation Recovery Policy exhibit.
NASDAQ
SunOpta Inc. filed an amendment to its 2025 Annual Report to provide required governance and compensation disclosures while confirming its pending acquisition by Refresco.
NASDAQ
European Wax Center, Inc. filed an amendment to its 2025 Annual Report to provide required Part III disclosures.
NYSE
Getty Images Holdings, Inc. filed an amendment to its 2025 Annual Report to provide required Part III governance and compensation disclosures.
NYSE
Sila Realty Trust, Inc. filed an amendment to its 2025 Annual Report to include proxy-related disclosures and updated executive certifications.
NYSE
Albertsons Companies, Inc. reports fiscal 2025 financial results, highlighting a 2.0% increase in identical sales and a $773.8 million charge related to an opioid settlement framework.
NYSE
Two Harbors Investment Corp. filed an amendment to its 2025 Annual Report to include required Part III governance and executive compensation disclosures.
NASDAQ
Terns Pharmaceuticals filed an amendment to its 2025 Annual Report to provide required Part III disclosures regarding executive compensation and corporate governance.
Trinseo PLC has filed an amendment to its 2025 annual report on Form 10-K/A to include previously omitted Part III information.
NASDAQ
Via Renewables, Inc. has filed an amendment to its 2025 annual report to include required information for Part III, covering directors, executive compensation, and corporate governance.
OQB
Liberty Star Uranium & Metals Corp. files its annual report for the fiscal year ended January 31, 2026, detailing exploration activities, financial condition, and forward-looking statements.
OTC.Pink
AppSoft Technologies filed its 2025 10-K, detailing a continued focus on its AI Profit Lab and Gamerfy incubator, while its mobile app and esports ventures remain paused due to financial constraints.
OQB
Glidelogic Corp. files its annual 10-K report for the fiscal year ended January 31, 2026, detailing its AI-driven content production strategy, minimal revenue generation, and significant going concern risks.
USBC, Inc. has filed an amendment to its Transition Report on Form 10-K for the period ending December 31, 2025, primarily to include Part III information.
Rein Therapeutics, Inc. files an amendment to its 2025 10-K report, primarily to include previously omitted information regarding directors, executive officers, and corporate governance.
OQB
Syra Health Corp. files Amendment No. 1 to its Form 10-K for the fiscal year ended December 31, 2025, to include previously omitted Part III information.
NASDAQ
Xenetic Biosciences, Inc. has amended its annual report to provide detailed disclosures on executive compensation, board governance, and significant consulting agreements with related parties.
NASDAQ
Wellgistics Health, Inc. filed an amendment to its 2025 Annual Report to restate governance disclosures and include a formal clawback policy.
NASDAQ
Paramount Skydance Corporation files an amendment to its 2025 Annual Report to provide required disclosures regarding executive compensation, corporate governance, and related party transactions.
NASDAQ
Creative Medical Technology Holdings files an amendment to its 2025 Annual Report, detailing executive compensation, governance, and related-party transactions.